Evidence map›Paper›PMID 38079163›Full record

ArticleJAMA2023

Pivotal Trial Demographic Representation and Clinical Development Times for Oncology Therapeutics.

Alissa K Wong, Jennifer E Miller, Maryam Mooghali, Reshma Ramachandran, Joseph S Ross, Joshua D Wallach

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alissa K WongDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Jennifer E MillerDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Maryam MooghaliDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Reshma RamachandranDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Joseph S RossDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Joshua D WallachDepartment of Epidemiology, Rollins School of Public Health, Atlanta, Georgia.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale-Mayo FDA Center for Excellence in Regulatory Science and InnovationU01FD005938 · FDA · YALE UNIVERSITY · PI Joseph Solomon Ross · 2016 to 2026
$25.4M
FDA HHS U01 FD005938NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicDemographyDrug ApprovalNeoplasmsDiffusion of InnovationHumansMedical OncologyTime FactorsUnited StatesUnited States Food and Drug Administration

Identifiers

PMID38079163
PMCPMC10714278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.